Kaken Pharmaceutical Co Ltd 2022 Integrated Report
The report covers FY2021 and presents KAKEN's value creation model across pharmaceuticals, agrochemicals and real estate. It describes the May 2022 Sustainability Policy and a four-step process for identifying, mapping, designating and reviewing priority material issues. Environmental data for the Shizuoka Site and Drug Research Center include 516 tons of waste generated and 18,428 t-CO2 emitted. It also details human-resource, health, safety and work-style programs.
Company: Kaken Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2022
Type: Integrated Report
Pages: 43
Back to company
Kaken Pharmaceutical Co Ltd
Corporate Report
The report covers FY2021 and presents KAKEN's value creation model across pharmaceuticals, agrochemicals and real estate. It describes the May 2022 Sustainability Policy and a four-step process for identifying, mapping, designating and reviewing priority material issues. Environmental data for the Shizuoka Site and Drug Research Center include 516 tons of waste generated and 18,428 t-CO2 emitted. It also details human-resource, health, safety and work-style programs.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Apr 1, 2021 - Mar 31, 2022
Fiscal Year
2021
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Water Consumption
Total Waste
Net Zero Target
Employees